Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 225-230

  Edmondson, S R ^a   Thumiger, S P ^a   Kaur, P ^b   Loh, B ^a   Koelmeyer, R ^b   Li, A ^b   Silha, J V ^c   Murphy, L J ^c   Wraight, C J ^a   Werther, G A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Epidermal homeostasis; IGF; IGFBP; Keratinocyte

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSGENIC MOUSE;

ADULT; ANIMALS; CELL PROLIFERATION; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; KERATINOCYTES; MICE; MICE, TRANSGENIC; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 20044376089     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06350.x     Document Type: Article

References (31)

1. Fuchs E, Byrne C. The epidermis: rising to the surface. Curr Opin Genet Dev 1994; 4:725-36.
2. Kaur P, Li A. Adhesive properties of human basal epidermal cells: an analysis of keratinocyte stem cells, transit amplifying cells, and postmitotic differentiating cells. J Invest Dermatol 2000; 114:413-20.
3. Edmondson SR, Thumiger SP, Werther GA et al. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24:737-64.
4. Liu JP, Baker J, Perkins AS et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (Igflr). Cell 1993; 75:59-72.
5. Barreca A, De DeLuca M, DelMonte P et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 1992; 151:262-8.
6. Tavakkol A, Elder JT, Griffiths CE et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992; 99:343-9.
7. Rudman SM, Philpott MP, Thomas GA et al. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol 1997; 109:770-7.
8. Krane JF, Gottlieb AB, Carter DM et al. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med 1991; 175:1081-90.
9. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23:824-54.
10. Batch JA, Mercuri FA, Edmondson SR et al. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Clin Endocr Metab 1994; 79:1444-9.
11. Wraight CJ, Edmondson SR, Fortune DW et al. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion. J Invest Dermatol 1997; 108:452-6.
12. Edmondson SR, Werther GA, Wraight CJ. Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT. J Invest Dermatol 2001; 116:491-7.
13. Wraight CJ, Werther GA. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J Invest Dermatol 1995; 105:602-7.
14. Edmondson SR, Murashita MM, Russo VC et al. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1. J Cell Physiol 1999; 179:201-7.
15. Wraight CJ, Murashita MM, Russo VC et al. A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-1 action. J Invest Dermatol 1994; 103:627-31.
16. Wraight CJ, Liepe IJ, White PJ et al. Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J Invest Dermatol 1998; 111:239-42.
17. Modric T, Silha JV, Shi Z et al. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 2001; 142:1958-67.
18. Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 1998; 95:3902-7.
19. Edmondson SR, Werther GA, Russell A et al. Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA. Endocrinology 1995; 136:4602-9.
20. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991; 3:243-66.
21. Edmondson SR, Baker NL, Oh J et al. Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int 2000; 58:62-70.
22. Birner P, Ritzi M, Musahl C et al. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded rnurine tissue. Am J Pathol 2001; 158:1991-6.
23. Ristow HJ. Effect of insulin-like growth factor-I/somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium. Growth Regul 1993; 3:129-37.
24. Hodak E, Gottlieb AB, Anzilotti M et al. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 1996; 106:564-70.
25. Ristow HJ. Increased synergistic effect of EGF and IGF-I on DNA synthesis of cultured psoriatic keratinocytes. Dermatology 1997; 195:213-19.
26. Wraight CJ, White PJ, McKean SC et al. Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat Biotechnol 2000; 18:521-6.
27. Xu S, Cwyfan-Hughes SC, van der Stappen JW et al. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J Clin Endocr Metab 1995; 80:2940-5.
28. Xu S, Cwyfan-Hughes SC, van der Stappen JW et al. Altered insulin-like growth factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J Invest Dermatol 1996; 106:109-12.
29. Hodak E, Gottlieb AB, Colen S et al. In vivo expression of the insulin-like growth factor-I (IGF-I) receptor in congenital pigmented nevi. J Cutan Pathol 1996; 23:19-24.
30. Liefer KM, Koster MI, Wang XJ et al. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 2000; 60:4016-20.
31. Wang X, Zinkel S, Polonsky K et al. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. Proc Natl Acad Sci USA 1997; 94:219-26.